Redirecting to https://www.amgen.com/newsroom/press-releases/2024/06/fda-approves-blincyto-blinatumomab-in-cd19positive-philadelphia-chromosomenegative-bcell-precursor-acute-lymphoblastic-leukemia-ball-in-the-consolidation-phase?_gl=1*a4eukt*_up*MQ..*_ga*MTIyNzAyMDc1MS4xNzE4NjM4Mzk0*_ga_CBMSV0J9VL*MTcxODYzODM5My4xLjEuMTcxODYzODQwNC4wLjAuMA.....

Click here if your browser doesn't automatically take you to this page.